Lifeward (LFWD) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$21.8M

Revenue (quarter)

$6.6M

Revenue growth (year over year)

+15.71%

Gross profit (trailing twelve months)

$7.8M

Gross margin

35.95%

Net income (trailing twelve months)

−$30.8M

Net income (quarter)

−$11.5M

Net income growth (year over year)

−75.54%

Net margin

−141.28%

Return on equity

−225.65%

EPS (trailing twelve months)

−$14.66

Book value per share

$4.32

P/E (trailing twelve months)

—

Price to book

1.44

Debt to assets

65.10%

Payout ratio

—

Dividend yield

—

Company profile

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.

• Is Lifeward (LFWD) profitable?

  No. Lifeward reported a net loss of $30.8M over the trailing twelve months.

• How much revenue does Lifeward (LFWD) make?

  Lifeward generated $21.8M in revenue over the trailing twelve months, up 15.71% year over year.

• How do I buy stock in Lifeward (LFWD)?

  LFWD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.